Showing results (331-340 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|December 12, 2024
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignanciesMelinda A Biernacki, Marie BleakleyExpert Review of Hematology|December 22, 2023
Ankle arthrodesis and total ankle replacement in patients with congenital bleeding disorders suffering from severe ankle arthropathyE Carlos Rodriguez-MerchanExpert Review of Hematology|December 4, 2023
A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantationMarianna Criscuolo, Nicola Fracchiolla, Francesca Farina, et al.Expert Review of Hematology|November 29, 2023
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infectionAndrea Boccatonda, Elena Campello, Chiara Simion, et al.Expert Review of Hematology|November 28, 2023
Predicting the development of hemophilic arthropathy in patients with hemophilia based on patient age: a retrospective single-center database studyRadovan Kubeš, Martin Stollin, Štěpán Magersky, et al.Expert Review of Hematology|January 16, 2024
Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experienceJosé Carlos Jaime-Pérez, Jesús Daniel Meléndez-Flores, Jorge Valdespino-Valdes, et al.Expert Review of Hematology|March 29, 2024
Clinical characteristics of HFE C282Y/H63D compound heterozygotes identified in a specialty practice: key differences from HFE C282Y homozygotesMukul Singal, Amir Mahmoud, Pradyumna Dinkar PhatakExpert Review of Hematology|February 29, 2024
Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysisYing Luo, Chen Li, Yuanchen Niu, et al.Expert Review of Hematology|November 18, 2023
The promise of novel treatments for severe chronic neutropeniaDavid C Dale, Audrey Anna Bolyard, Vahagn MakaryanExpert Review of Hematology|July 5, 2023
Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemiasKieran D Sahasrabudhe, Mary Albrethsen, Alice S MimsPageof 157